Clinical Trial Update: An Observational Study of the Impact of RoActemra/Actemra on Fatigue in Patients With Rheumatoid Arthritis (PEPS)

View source ↗

Summary

This is a completed observational study evaluating the impact of RoActemra/Actemra on fatigue in patients with rheumatoid arthritis, with results posted in 2016…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• RoActemra/Actemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2016-06-23